|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.20 CNY | +0.88% |
|
+11.11% | -2.38% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 5.24% | 5.53% | 13.19x | 2.47x | 0.54x | 4.27x | 7.05x | 2.88B | |
| 2.3% | 2.6% | 16.19x | 1.69x | 0.72x | 7.53x | 9.5x | 5.97B | |
| 3.38% | 3.72% | 12.7x | 1.91x | 0.8x | 5.81x | 7.61x | 3.58B | |
| 4% | 4.4% | 16.13x | 7.3x | 0.98x | 7.32x | 10.18x | 3.37B | |
| 5.69% | 6.32% | 14.53x | 4.39x | 1.23x | 7.48x | 14.5x | 3.25B | |
| 1.77% | 2.15% | 23.19x | 4.06x | 0.66x | 8.52x | 13.95x | 1.72B | |
| 0.01% | -.--% | -92.5x | 3.04x | 0.48x | 17.95x | 108.55x | 1.61B | |
| 5.61% | 6.31% | 11.8x | 2.37x | 0.87x | 7.07x | 13.34x | 984M | |
| 4.54% | 5.11% | 11.19x | 0.8x | 0.26x | 2.52x | 5.19x | 883M | |
| 1.32% | 1.91% | 27.7x | 7.46x | 0.99x | 13.58x | 21.54x | 816M | |
| 0.38% | 0.39% | 13.73x | 1.85x | 0.66x | 8.14x | 13.15x | 673M | |
| -.--% | -.--% | -5.72x | 1.4x | 0.53x | -34.49x | -9.75x | 551M | |
| 1.76% | 12.74% | 7.05x | 0.74x | 0.24x | 3.79x | 4.55x | 514M | |
| Average | 2.77% | 3.94% | 5.32x | 3.04x | 0.69x | 4.58x | 16.87x | 2.06B | |
| Weighted average by Cap. | 3.27% | 3.84% | 8.46x | 3.22x | 0.77x | 6.69x | 15.87x |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
